- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Myelodysplastic/Myeloproliferative Neoplasm Overlap Syndrome
Total 7121 results
-
McMaster UniversityCBSRecruitingMyelodysplastic SyndromeCanada
-
Stanford UniversityNotable Labs Inc.Active, not recruitingMyelodysplastic SyndromesUnited States
-
Michael PfeilstöckerCelgene CorporationCompletedMyelodysplastic SyndromesAustria
-
CelgeneCompletedMyelodysplastic SyndromeUnited States, Germany
-
Indiana University School of MedicineTerminatedMyelodysplastic Syndromes | Leukemia, Myeloid, Acute | Leukemia, Lymphoid | Leukemia, Myelogenous, ChronicUnited States
-
Emory UniversityNo longer availableAcute Myeloid Leukemia | Chronic Myeloid Leukemia | Myelodysplastic SyndromeUnited States
-
Radboud University Medical CenterTerminatedLymphoma | Leukemia, Myeloid | Myelodysplastic Syndrome | Leukemia, Lymphocytic | Leukemia, Myeloid, ChronicNetherlands
-
BioLineRx, Ltd.CompletedAplastic Anemia | Hypoplastic Myelodysplastic SyndromeUnited States
-
Ruijin HospitalRecruitingMyelodysplastic Syndromes | Myelodysplastic Syndrome With Excess Blasts-2 | Myelodysplastic Syndrome With Excess Blasts-1China
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedChronic Myelomonocytic Leukemia | Myelodysplastic Syndrome | High Risk Myelodysplastic Syndrome | Acute Myeloid Leukemia With Multilineage Dysplasia | Blasts 20-30 Percent of Bone Marrow Nucleated Cells | Blasts 20-30 Percent of Peripheral Blood White Cells | IPSS Risk Category Intermediate-2United States
-
University Hospital, Clermont-FerrandMinistry of Health, France; French Society of HematologyRecruitingLymphoma, Non-Hodgkin | Myelodysplastic Syndromes | Hodgkin Lymphoma | Chronic Lymphocytic Leukemia | Myeloma | Acute Leukemia in Remission | Myeloproliferative SyndromeFrance
-
Peter MacCallum Cancer Centre, AustraliaGlaxoSmithKline; Celgene CorporationCompletedMyelodysplastic Syndromes (MDS) | Acute Myeloid Leukaemia (AML)Australia
-
Otsuka Pharmaceutical Co., Ltd.Active, not recruitingLower-risk MyelodysplasticJapan
-
Hoag Memorial Hospital PresbyterianCancer Biotherapy Research GroupCompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Unspecified Adult Solid Tumor, Protocol Specific | Multiple Myeloma and Plasma Cell Neoplasm | Precancerous/Nonmalignant ConditionUnited States
-
Northwestern UniversityNational Cancer Institute (NCI)CompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Multiple Myeloma and Plasma Cell Neoplasm | Graft Versus Host Disease | Precancerous/Nonmalignant ConditionUnited States
-
Novartis PharmaceuticalsActive, not recruitingAcute Myeloid Leukemia (AML) | High-risk Myelodysplastic Syndrome (MDS)Spain, Singapore, Australia, Germany, Italy, Finland, United States
-
University of UlmTerminatedAcute Myeloid Leukemia (AML) | High-risk Myelodysplastic Syndrome (MDS)Germany
-
National Cancer Institute (NCI)CompletedChronic Myelomonocytic Leukemia | Recurrent Adult Acute Myeloid Leukemia | Previously Treated Myelodysplastic Syndromes | Refractory Anemia With Excess Blasts | Refractory Anemia With Excess Blasts in TransformationUnited States
-
Peking Union Medical College HospitalNot yet recruitingMyelodysplastic Syndromes
-
The First Affiliated Hospital of Soochow UniversityEnrolling by invitation
-
CelgeneCompleted
-
Groupe Francophone des MyelodysplasiesCelgeneCompletedLenalidomide Combined to Azacitidine in Intermediate-2 or High Risk MDS With Del 5q (GFM-AZA-REV-09)Myelodysplastic SyndromesFrance
-
Sanquin Research & Blood Bank DivisionsNetherlands: Ministry of Health, Welfare and SportsWithdrawnMyelodysplastic SyndromesNetherlands
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedLymphoma | Lymphoma, Non-Hodgkin | Myelodysplastic Syndromes | Leukemia | Leukemia, Myeloid | Hodgkin Disease | Leukemia, Myelomonocytic, Chronic | Graft vs Host Disease | Leukemia, Lymphocytic | Lymphoma, Mantle-cellUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedAcute Myeloid Leukemia (AML) | Myelodysplastic Syndrome (MDS) | Chronic Myeloid Leukemia (CML)United States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute... and other collaboratorsRecruitingHematopoietic and Lymphoid Cell Neoplasm | Acute Lymphoblastic Leukemia | Myelodysplastic Syndrome | Myelodysplastic Syndrome With Excess Blasts | Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Acute Biphenotypic LeukemiaUnited States
-
Maria Sklodowska-Curie National Research Institute...KCRINot yet recruitingAcute Myeloid Leukemia Myelodysplastic SyndromesPoland
-
Hoffmann-La RocheTerminatedMyelodysplastic Syndromes, Myelogenous Leukemia, AcuteUnited States, Canada, Germany
-
Minovia Therapeutics Ltd.RecruitingMyelodysplastic SyndromesIsrael
-
M.D. Anderson Cancer CenterRecruitingMyelodysplastic SyndromesUnited States
-
Anhui Provincial HospitalRecruitingMyelodysplastic SyndromesChina
-
GWT-TUD GmbHCelgeneRecruitingMyelodysplastic SyndromesAustria, Germany, Spain, Switzerland
-
AkesoRecruitingMyelodysplastic SyndromeChina
-
University Hospital, ToulouseRecruitingMyelodysplastic SyndromesFrance
-
Peking University People's HospitalRecruiting
-
Institut Paoli-CalmettesRecruiting
-
Yonsei UniversityRecruitingMyelodysplastic SyndromeKorea, Republic of
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedMyelodysplastic SyndromesUnited States
-
Geron CorporationActive, not recruitingMyelodysplastic SyndromesUnited States, Canada, Belgium, Spain, Czechia, Korea, Republic of, United Kingdom, Netherlands, Israel, Germany, Russian Federation, Switzerland, Italy, France, Turkey, Poland, Ukraine
-
Astex Pharmaceuticals, Inc.Active, not recruitingMyelodysplastic SyndromesSpain, United States, Belgium, Canada, Germany, Italy
-
Astex Pharmaceuticals, Inc.TerminatedMyelodysplastic SyndromesUnited States
-
Novartis PharmaceuticalsActive, not recruitingMyelodysplastic SyndromesCzechia, Hungary, Japan, Taiwan, United States, Belgium, Italy, United Kingdom, Korea, Republic of, Hong Kong, Austria, Germany, Turkey, Spain, Greece, France, Canada
-
Shanghai Antengene Corporation LimitedTerminated
-
Washington University School of MedicineJazz PharmaceuticalsActive, not recruitingMyelodysplastic SyndromesUnited States
-
National Cancer Institute (NCI)Active, not recruiting
-
Eisai Inc.CompletedMyelodysplastic SyndromeUnited States
-
Fundación General de la Universidad de SalamancaCelgene CorporationCompletedMyelodysplastic SyndromeGermany, Spain, France
-
Sumitomo Pharma Co., Ltd.Completed
-
Memorial Sloan Kettering Cancer CenterM.D. Anderson Cancer Center; Columbia University; Karyopharm Therapeutics IncCompletedMyelodysplastic SyndromesUnited States